140 related articles for article (PubMed ID: 6487500)
1. 2-Hydroxylation of ethinyloestradiol in relation to the oxidation of sparteine and antipyrine.
Back DJ; Maggs JL; Purba HS; Newby S; Park BK
Br J Clin Pharmacol; 1984 Oct; 18(4):603-7. PubMed ID: 6487500
[TBL] [Abstract][Full Text] [Related]
2. Deficient metabolism of debrisoquine and sparteine.
Inaba T; Otton SV; Kalow W
Clin Pharmacol Ther; 1980 Apr; 27(4):547-9. PubMed ID: 7357813
[TBL] [Abstract][Full Text] [Related]
3. Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine.
Eichelbaum M; Bertilsson L; Säwe J
Br J Clin Pharmacol; 1983 Mar; 15(3):317-21. PubMed ID: 6849767
[TBL] [Abstract][Full Text] [Related]
4. Influence of enzyme induction and inhibition on the oxidation of nifedipine, sparteine, mephenytoin and antipyrine in humans as assessed by a "cocktail" study design.
Schellens JH; van der Wart JH; Brugman M; Breimer DD
J Pharmacol Exp Ther; 1989 May; 249(2):638-45. PubMed ID: 2724144
[TBL] [Abstract][Full Text] [Related]
5. Theophylline metabolism in relation to antipyrine, debrisoquine, and sparteine metabolism.
Dahlqvist R; Bertilsson L; Birkett DJ; Eichelbaum M; Säwe J; Sjöqvist F
Clin Pharmacol Ther; 1984 Jun; 35(6):815-21. PubMed ID: 6734034
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of estrogen 2-hydroxylase.
Purba HS; Back DJ; Breckenridge AM
J Steroid Biochem; 1986 May; 24(5):1091-3. PubMed ID: 3724146
[TBL] [Abstract][Full Text] [Related]
7. Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes.
Li AP; Hartman NR; Lu C; Collins JM; Strong JM
Br J Clin Pharmacol; 1999 Nov; 48(5):733-42. PubMed ID: 10594476
[TBL] [Abstract][Full Text] [Related]
8. Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation.
Danhof M; Idle JR; Teunissen MW; Sloan TP; Breimer DD; Smith RL
Pharmacology; 1981; 22(6):349-58. PubMed ID: 7267701
[TBL] [Abstract][Full Text] [Related]
9. The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites.
Purba HS; Maggs JL; Orme ML; Back DJ; Park BK
Br J Clin Pharmacol; 1987 Apr; 23(4):447-53. PubMed ID: 3555579
[TBL] [Abstract][Full Text] [Related]
10. Role of rat cytochromes P450 in the oxidation of 17α-ethinylestradiol.
Bořek-Dohalská L; Valášková P; Černá V; Stiborová M
Environ Toxicol Pharmacol; 2014 Nov; 38(3):852-60. PubMed ID: 25461545
[TBL] [Abstract][Full Text] [Related]
11. The influence of enzyme induction on polymorphic sparteine oxidation.
Eichelbaum M; Mineshita S; Ohnhaus EE; Zekorn C
Br J Clin Pharmacol; 1986 Jul; 22(1):49-53. PubMed ID: 3741726
[TBL] [Abstract][Full Text] [Related]
12. A study on 17alpha-ethinylestradiol metabolism in rat and Pleurotus ostreatus.
Borek-Dohalska L; Valaskova P; Kubickova B; Sulc M; Kresinova Z; Cajthaml T; Stiborova M
Neuro Endocrinol Lett; 2015; 36 Suppl 1():5-12. PubMed ID: 26757108
[TBL] [Abstract][Full Text] [Related]
13. Effect of rifampicin treatment on the metabolism of oestradiol and 17alpha-ethinyloestradiol by human liver microsomes.
Bolt HM; Kappus H; Bolt M
Eur J Clin Pharmacol; 1975 Jun; 8(5):301-7. PubMed ID: 1233229
[TBL] [Abstract][Full Text] [Related]
14. The relationship between paroxetine and the sparteine oxidation polymorphism.
Sindrup SH; Brøsen K; Gram LF; Hallas J; Skjelbo E; Allen A; Allen GD; Cooper SM; Mellows G; Tasker TC
Clin Pharmacol Ther; 1992 Mar; 51(3):278-87. PubMed ID: 1531950
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of biliary and urinary 2-hydroxylated metabolites of [6,7-3H]17 alpha-ethynylestradiol in women.
Maggs JL; Park BK
Contraception; 1985 Aug; 32(2):173-82. PubMed ID: 4075792
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ethinyloestradiol and tolbutamide metabolism by quinoline derivatives in vitro.
Riviere JH; Back DJ
Chem Biol Interact; 1986 Oct; 59(3):301-8. PubMed ID: 3769058
[TBL] [Abstract][Full Text] [Related]
17. Quinidine kinetics after a single oral dose in relation to the sparteine oxidation polymorphism in man.
Brøsen K; Davidsen F; Gram LF
Br J Clin Pharmacol; 1990 Feb; 29(2):248-53. PubMed ID: 2306418
[TBL] [Abstract][Full Text] [Related]
18. Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 alpha-ethinyloestradiol. Relative activities of rat and human liver enzymes.
Ball SE; Forrester LM; Wolf CR; Back DJ
Biochem J; 1990 Apr; 267(1):221-6. PubMed ID: 2327982
[TBL] [Abstract][Full Text] [Related]
19. [Sparteine oxidation by hepatic cytochrome P-450 in patients with Parkinson's disease].
Yoshino H; Hattori Y; Imai H; Narabayashi H; Chiba K
Rinsho Shinkeigaku; 1993 Mar; 33(3):261-5. PubMed ID: 8334787
[TBL] [Abstract][Full Text] [Related]
20. The biotransformation of 17 alpha-ethynyl[3H]estradiol in the rat: irreversible binding and biliary metabolites.
Maggs JL; Grabowski PS; Rose ME; Park BK
Xenobiotica; 1982 Oct; 12(10):657-68. PubMed ID: 7157835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
